Fmr LLC 9 Meters Biopharma, Inc. Transaction History

Fmr LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.64 $31 - $78	-122 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.52 - $1.0 $63 - $122	122 New	122 $0
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $1,735 - $2,375	-1,685 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $1,752 - $2,527	1,685 New	1,685 $1,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.